Hepcludex (bulevirtide) / Gilead |
2019-001213-17: Efficacy and Safety of bulevirtide in patients with Chronic Hepatitis Delta |
|
|
| Not yet recruiting | 3 | 150 | Europe | bulevirtide, [bulevirtide], Lyophilisate for solution for injection | Gilead Sciences, Inc., Gilead Sciences, Inc, MYR GmbH, MYR GmbH, Gilead Sciences, Inc. | Chronic Hepatitis Delta, Chronic Hepatitis Delta, Diseases [C] - Virus Diseases [C02] | | | | |
MYR 301, NCT03852719: Study to Assess Efficacy and Safety of Bulevirtide in Participants With Chronic Hepatitis Delta (CHD) |
|
|
| Completed | 3 | 150 | Europe, US, RoW | Bulevirtide, Myrcludex B, Hepcludex® | Gilead Sciences | Chronic Hepatitis Delta | 11/20 | 08/24 | | |
| Not yet recruiting | 2 | 120 | Europe | Myrcludex B, Powder for solution for injection, Film-coated tablet, Viread | Hepatera LLC, Hepatera LLC | Chronic Hepatitis D, Chronic Hepatitis D infection, Diseases [C] - Digestive System Diseases [C06] | | | | |
2019-001485-15: This study will use an investigational product (bulevirtide) for the treatment of chronic hepatitis Delta to learn the therapeutic effect, and safety of the drug in humans. |
|
|
| Ongoing | 2 | 175 | Europe | Bulevirtide, Lyophilisate for solution for injection, Solution for injection, Pegasys | MYR GmbH, MYR GmbH | Chronic Hepatitis Delta, Chronic Hepatitis Delta, Diseases [C] - Virus Diseases [C02] | | | | |
NCT05765344: Study of Bulevirtide in Participants Who Have Normal or Impaired Liver Function |
|
|
| Recruiting | 1 | 72 | US | Bulevirtide, Hepcludex®, Myrcludex B | Gilead Sciences | Chronic Hepatitis D Infection | 02/25 | 02/25 | | |
NCT05760300: A Multiple-Dose Study of Bulevirtide in Participants With Normal and Impaired Renal Function |
|
|
| Recruiting | 1 | 80 | US | Bulevirtide (BLV), Hepcludex®, Myrcludex B | Gilead Sciences | Chronic Hepatitis D Infection | 05/26 | 05/26 | | |
NCT05718700: Study of Bulevirtide in Participants With Chronic Hepatitis D Infection |
|
|
| Recruiting | N/A | 170 | Europe | Bulevirtide, Hepcludex® | Gilead Sciences | Chronic Hepatitis D Infection | 11/27 | 11/27 | | |